EndoQuest Robotics has received FDA approval to proceed with the final enrollment phase of its pivotal Paradigm trial evaluating a robotic endoluminal system for gastrointestinal procedures. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback